Oral Abstract Session:
126. Health Care-Related Infections II
Saturday, October 31, 2009: 2:00 PM-4:00 PM
Room: 107-AB

Tracks: Adult ID, Pediatric ID

Moderators:  Loren Miller, MD, MPH, and Paul Ananth Tambyah, MD, FSHEA, National University of Singapore


2:00 PM
Paul Ananth Tambyah, MD, FSHEA

2:00 PM
Loren Miller, MD, MPH

2:00 PM
H1N1 Influenza in employees of a tertiary care hospital: experience and lessons to be learned from the epidemic in Mexico
María Bourlon de los ríos, MD ; Ayleen Cardenas, Ch ; Claudia Colín Castro, Ch ; Alethse De la Torre Rosas, MD ; Rafael Franco-Cendejas, MD ; Arturo Galindo Fraga, MD MSc ; Luis García Andrade, B ; Violeta Ibarra González, MSc ; Patricia Leal Morán, MD ; Fernando Ledesma, BS ; Alejandro Macías Hernández, MD MS ; Julia Martínez López, Ch ; Sarbelio Moreno Espinosa, MD, PhD ; Teresa Muñoz Trejo, Ch ; Pilar Ramos Cervantes, MSc ; Guillermo Ruiz Palacios, MD PhD ; Jesús Ruiz Quiñones, MD

2:00 PM
The first randomised, controlled clinical trial of surgical masks compared to fit-tested and non-fit tested N95 masks in the prevention of respiratory virus infection in hospital health care workers in Beijing, China
Simon Cauchemez, BSc, PhD ; Dominic Dwyer, MBBS, FRACP, FRCP, PhD ; C. Raina MacIntyre, MBBS, M App Epid, PhD, FRACP, FAFPHM ; Ferguson Neil, BSc, PhD ; Yang Peng, MD, PhD ; Holly Seale, BSc, PhD ; Quany Wang, MD, MPH ; Shi Weixian, MD, PhD

2:00 PM
Risk Factors for Infection of Health Care Providers Exposed to Patients with Novel Influenza A (H1N1) Virus _ California, 2009
Dianna M. Blau, DVM, PhD ; Nila Dharan, MD ; Saumil Doshi, MD ; Lyn Finelli, DrPH, MS ; Michele Ginsberg, MD ; R. Gladden, PhD ; Kathy Hancock, PhD ; Jenifer Jaeger, MD ; Seema Jain, MD ; Jacqueline Katz, PhD ; Paula Kriner, MPH ; Christine Mattson, PhD ; Elissa Meites, MD, MPH ; Sonja Olsen, PhD ; Minal Patel, MD ; David Sugerman, MD, MPH

2:00 PM
Characterization of Methicillin Resistant Staphylococcus Aureus (MRSA) carriage among Healthcare Workers (HCW) at a Tertiary Care Hospital
Kerri Augustino, BS ; Andy Blake, BA ; John Christie, MD, PhD ; Carlos Guerra, MD ; Amy Pearson, BSN, MPH ; Keith Ramsey, MD

2:00 PM
Clinical Outcomes for Patients with MRSA HAP Treated with Vancomycin Versus Linezolid: Results from the IMPACT-HAP Study
Kimbal Ford, PharmD ; Paula Peyrani, MD ; Julio Ramirez, MD ; Ernesto Scerpella, MD ; the IMPACT-HAP Study Group ; Timothy Wiemken, MPH ; Marcus Zervos, MD

2:00 PM
Brucella Laboratory Exposures in the United States, 2008
David Blaney, MD, MPH ; Elizabeth Bosserman, MPH ; Duy Bui, BS ; Marta Guerra, DVM, PhD, MPH ; Alex Hoffmaster, PhD ; Sean Shadomy, DVM, MPH ; Theresa Smith, MD, MPH ; Robyn Stoddard, DVM, PhD

2:00 PM
Vancomycin (VAN) Exposure and its Relation to Mortality from Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia are Affected by Severity of Illness
Yehuda Carmeli, MD, MPH ; Varun Chawla, MD MPH ; Yoav Golan, MD MS ; Adolf Karchmer, MD, FIDSA ; Todd Pollack, MD ; David Snydman, MD, FIDSA

2:00 PM
Activity of Omiganan (OMI) 1% Gel, a Novel Cationic Peptide in Preventing Catheter Related Infections (CRI): Final Results of a Phase 3 Trial
Rafael Cantón, PhD ; Bruno FranÇois, MD ; Catherine Hardalo, MD ; Ronald Jones, MD ; Laurent Mereghetti, MD, PhD ; Marie-Cecile Ploy, PharmD, PhD ; Miguel Sanchez, MD, PhD

CME Credits:

ACPE Credits:



L. Miller, None

P. A. Tambyah, None

See more of: Oral Abstract Session